AMT
28
3
EXR
37
15
PM
56
2
KSS
32
-2
APH
58
5
NOV
49
-6
CPB
22
-3
UNM
63
-2
HAL
36
-7
LLY
37
4
EBAY
62
12
MSI
47
4
BDX
65
2
RSG
53
3
EQIX
59
2
JCI
45
4
NFLX
59
-2
MTCH
42
-4
AMP
52
6
ICE
45
3
AMT
28
3
EXR
37
15
PM
56
2
KSS
32
-2
APH
58
5
NOV
49
-6
CPB
22
-3
UNM
63
-2
HAL
36
-7
LLY
37
4
EBAY
62
12
MSI
47
4
BDX
65
2
RSG
53
3
EQIX
59
2
JCI
45
4
NFLX
59
-2
MTCH
42
-4
AMP
52
6
ICE
45
3
Financhill
Back

Ultralife Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
39

ULBI
Ultralife

Last Price:
$7.36
Seasonality Move:
8.62%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
39
Ultralife (ULBI) is a Sell

Is Ultralife a Buy, Sell or Hold?

  • The current Ultralife [ULBI] share price is $7.39. The Score for ULBI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ULBI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ULBI Stock Price Chart

What is Ultralife's stock price today?

  • The Ultralife share price today is $7.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ULBI is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

ULBI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 44.02 Sell
Chaikin Money Flow: -4707 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.34 - 7.78) Sell
Bollinger Bands (100): (7.63 - 9.75) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

ULBI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.44 Sell
20-day SMA: 7.52 Sell
50-day SMA: 7.82 Sell
200-day SMA: 9.65 Sell
8-day EMA: 7.47 Sell
20-day EMA: 7.52 Sell
50-day EMA: 7.88 Sell
200-day EMA: 8.83 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

Ultralife Earnings Growth & ULBI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Ultralife Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):